JP2007534743A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007534743A5 JP2007534743A5 JP2007510157A JP2007510157A JP2007534743A5 JP 2007534743 A5 JP2007534743 A5 JP 2007534743A5 JP 2007510157 A JP2007510157 A JP 2007510157A JP 2007510157 A JP2007510157 A JP 2007510157A JP 2007534743 A5 JP2007534743 A5 JP 2007534743A5
- Authority
- JP
- Japan
- Prior art keywords
- cell activator
- antigen
- vaccine
- cat
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56495904P | 2004-04-26 | 2004-04-26 | |
| US62906904P | 2004-11-18 | 2004-11-18 | |
| PCT/IB2005/001485 WO2005102385A1 (en) | 2004-04-26 | 2005-04-25 | Adjuvant composition and methods for its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007534743A JP2007534743A (ja) | 2007-11-29 |
| JP2007534743A5 true JP2007534743A5 (enExample) | 2008-06-19 |
Family
ID=34969994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007510157A Withdrawn JP2007534743A (ja) | 2004-04-26 | 2005-04-25 | アジュバント組成物およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070218086A1 (enExample) |
| EP (1) | EP1761278B1 (enExample) |
| JP (1) | JP2007534743A (enExample) |
| AT (1) | ATE419008T1 (enExample) |
| AU (1) | AU2005235271A1 (enExample) |
| CA (1) | CA2564562A1 (enExample) |
| DE (1) | DE602005012097D1 (enExample) |
| WO (1) | WO2005102385A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212666D0 (en) * | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
| EP1720567A2 (en) * | 2004-02-10 | 2006-11-15 | Innate Pharma | Composition and method for the treatment of carcinoma |
| WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| CA2602223A1 (en) * | 2005-03-22 | 2006-10-05 | Christian Belmant | New class of yo t cells activators and use thereof |
| EP1924279A2 (en) * | 2005-09-07 | 2008-05-28 | The Secretary of State for Defence | Adjuvanted vaccine |
| ITMI20060366A1 (it) * | 2006-03-01 | 2007-09-02 | C4T S C A R L | Composti organo tiopirosfosfati metodo per prepararli e composizioni che li contengono |
| EP1878440A1 (en) * | 2006-07-13 | 2008-01-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds |
| EP2040744B1 (en) * | 2006-07-25 | 2016-03-09 | The Secretary of State for Defence | Live vaccine strains of francisella |
| EP2123285A1 (en) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy |
| EP2324040B1 (en) | 2008-09-10 | 2014-01-01 | Innate Pharma | Novel polymorphic form of chdmapp, method of preparation thereof, and pharmaceutical composition comprising same |
| WO2010035119A2 (en) * | 2008-09-29 | 2010-04-01 | Cadila Pharmaceuticals Ltd. | Vaccine adjuvants |
| GB0901411D0 (en) * | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| WO2014145038A1 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Vaccines with biomolecular adjuvants |
| KR102451441B1 (ko) * | 2020-06-25 | 2022-10-12 | 대한민국 | 신규 면역증강제 및 이를 포함하는 백신 조성물 |
| WO2021261635A1 (ko) * | 2020-06-26 | 2021-12-30 | 대한민국(농림축산식품부 농림축산검역본부장) | 신규 면역증강제 및 이를 포함하는 백신 조성물 |
| MX2023014899A (es) * | 2021-06-28 | 2024-04-29 | Byondis Bv | Nuevos conjugados que comprenden fosfoantígenos y su uso en terapia. |
| GB202114311D0 (en) * | 2021-10-06 | 2021-11-17 | Molecular Attraction Ab | New compositions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8913737D0 (en) | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
| US5639653A (en) | 1993-07-19 | 1997-06-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy | Method for proliferating Vγ2Vδ2 T cells |
| US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| WO1998050567A1 (en) | 1997-05-02 | 1998-11-12 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
| BE1011282A3 (fr) * | 1997-07-14 | 1999-07-06 | Solvay | Composition a base de polyethylene et procede de fabrication d'objets faconnes a partir de la composition. |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
| FR2782721B1 (fr) * | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| ES2315411T3 (es) * | 2001-07-20 | 2009-04-01 | Bioagency Ag | Compuestos organofosforados para la activacion de celulas t gamma/delta. |
| JP2005500336A (ja) | 2001-07-25 | 2005-01-06 | ニューヨーク・ユニバーシティ | 感染および癌に対するワクチンのためのアジュバントとしてのグリコシルセラミドの使用 |
| EP1470217A1 (en) * | 2001-10-31 | 2004-10-27 | Université Libre de Bruxelles | Generation and use of dendritic cells |
| FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| ATE441420T1 (de) | 2002-12-02 | 2009-09-15 | Innate Pharma | Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen |
| US20070025960A1 (en) * | 2003-05-16 | 2007-02-01 | University Of Maryland Biotechnology Institute | Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
| CA2547008A1 (en) | 2003-12-02 | 2005-06-16 | Innate Pharma | New class of gamma delta t cells activators and use thereof |
-
2005
- 2005-04-25 WO PCT/IB2005/001485 patent/WO2005102385A1/en not_active Ceased
- 2005-04-25 AU AU2005235271A patent/AU2005235271A1/en not_active Abandoned
- 2005-04-25 JP JP2007510157A patent/JP2007534743A/ja not_active Withdrawn
- 2005-04-25 AT AT05747242T patent/ATE419008T1/de not_active IP Right Cessation
- 2005-04-25 US US11/587,476 patent/US20070218086A1/en not_active Abandoned
- 2005-04-25 CA CA002564562A patent/CA2564562A1/en not_active Abandoned
- 2005-04-25 EP EP05747242A patent/EP1761278B1/en not_active Expired - Lifetime
- 2005-04-25 DE DE602005012097T patent/DE602005012097D1/de not_active Expired - Lifetime